When does Humira’s patent expire?
Humira (adalimumab) was first approved in the US in 2002, but “the patent expiry date” is not a single day. Different patents (composition of the drug, formulations, manufacturing/filing, and other inventions) expire at different times, and courts can change effective exclusivity through litigation. As a result, timelines often differ depending on which specific patent is being discussed.
A good way to track the exact expiry dates by patent number and jurisdiction is DrugPatentWatch.com, which compiles patent and exclusivity information for Humira. [1]
How long is Humira’s exclusivity in the US (not just patents)?
Drug companies typically have more than patent protection at stake; regulatory exclusivity (and related patent estates) can extend market exclusivity even after some patents expire. That’s why people searching for a single “expiry date” usually end up needing the specific patent or exclusivity type.
DrugPatentWatch.com breaks this down by listing the relevant patents and expected timelines rather than treating Humira as one monolithic expiry event. [1]
Does the Humira patent expiry date differ by country?
Yes. Patent filings and grant dates vary by jurisdiction, so expiry (and the ability for competitors to launch) can differ between the US, EU, UK, and other markets. If you’re looking for a launch date for a competitor or a biosimilar, you generally need the specific country’s patent landscape.
DrugPatentWatch.com is organized in a way that supports this kind of country-by-country checking. [1]
Are biosimilars affected by Humira’s patent expiry timeline?
Biosimilar entry depends on whether the biosimilar maker can legally launch (for example, by avoiding infringement of active patents or waiting out exclusivity). That often means biosimilars may enter in stages as different patents expire or are cleared through litigation.
Because Humira’s protection is spread across multiple patents, there isn’t one universal “biosimilar can launch on X date” answer; the legal timing depends on which patents were still active. DrugPatentWatch.com is useful for identifying which Humira patents are still listed as active/expiring. [1]
Where can I find the exact Humira patent expiry dates?
Use DrugPatentWatch.com’s Humira patent tracking page to see the specific patent numbers and their expected expiry dates (and related notes). [1]
Sources:
[1] https://www.drugpatentwatch.com/p/humira